.
ResMed’s Inc (ASX:RMD) profit rose nine per cent in its first quarter, buoyed by revenue growth and widening margins.
However, that result missed analysts’ expectations.
For the quarter ended September 30, ResMed posted a profit of $80.9 million, up from $71.3 million, in the previous corresponding period.
Revenue rose 5 per cent to $357.7 million.
ResMed develops products for the treatment of respiratory disorders, including flow generators and humidifiers.
ResMed delivered a net profit of $331 million in fiscal 2013.
News: ResMed profits rise
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RMD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$31.16 |
Change
0.100(0.32%) |
Mkt cap ! $19.88B | |||
| Open | High | Low | Value | Volume |
| $30.96 | $31.16 | $30.93 | $31.57M | 1.014M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1958 | $31.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $31.19 | 1266 | 1 |
View Market Depth
| Last trade - 16.10pm 30/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$31.15 |
Change
0.100 ( 0.28 %) |
||||
| Open | High | Low | Volume | ||
| $30.94 | $31.16 | $30.94 | 119952 | ||
| Last updated 15.59pm 30/05/2024 ? | |||||
| RMD (ASX) Chart |